Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

By Saarto Tiina   Vehmanen Leena   Virkkunen Pekka   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite

Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study

By Schaapveld Michael   Vries Elisabeth   Graaf Winette   Otter Renée   Willemse Pax  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 10, 2004-10 ,pp. : 581-590

Springer Publishing Company

Access to resources Recommend Favorite

Thirty-year follow-up of chemo/hormonal therapy in node-positive breast cancer

By Gordon N.   Silverman P.   Lasheen W.   Meinert J.   Siminoff L.  

Breast Cancer Research and Treatment, Vol. 102, Iss. 3, 2007-05 ,pp. : 301-312

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-up Study of a Prospective Multicenter Sentinel Node Trial: Molecular Detection of Breast Cancer Sentinel Node Metastases

By Verbanac Kathryn   Min Christopher   Mannie Ann   Lu Jianfen   O’Brien Kevin   Rosman Martin   Tafra Lorraine  

Annals of Surgical Oncology, Vol. 17, Iss. 3, 2010-10 ,pp. : 368-377

Springer Publishing Company

Access to resources Recommend Favorite

Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer

By Colleoni M.   Price K.   Castiglione-Gertsch M.   Goldhirsch A.   Coates A.   Lindtner J.   Collins J.   Gelber R.D.   Thurlimann B.   Rudenstam C.M.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1693-1700

Elsevier

Access to resources Recommend Favorite